{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:25:08Z","timestamp":1795019108699,"version":"4.10.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.semerg.2026.102845","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:25:45Z","timestamp":1790688345000},"page":"102845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular risk factors and their evolution in a primary care psoriasis cohort: The REPICA study"],"prefix":"10.1016","volume":"52","author":[{"given":"J.A.","family":"Heras-Hitos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Segura-Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Polo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cinza-Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Montes-Belloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Velilla-Zancada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Palacios-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"P\u00e9rez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vale-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Mart\u00ednez Guillam\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Rinc\u00f3n Ricote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102845_bib0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","article-title":"Psoriasis","volume":"11","author":"Armstrong","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.semerg.2026.102845_bib0245","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2026.102845_bib0250","article-title":"The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study","volume":"8","author":"Damiani","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semerg.2026.102845_bib0255","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0260","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of psoriasis: a worldwide global study","volume":"105","author":"Skayem","year":"2025","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semerg.2026.102845_bib0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.medcli.2024.08.019","article-title":"Increasing prevalence of psoriasis in Spain: a population-based study (2018\u20132022)","volume":"164","author":"Cayuela","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.semerg.2026.102845_bib0270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2023.5439","article-title":"Patient-reported outcome measures for health-related quality of life in patients with psoriasis: a systematic review","volume":"160","author":"P\u00e9rez-Chada","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0275","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102845_bib0280","first-page":"718","article-title":"Cardiovascular comorbidity in psoriasis \u2013 psoriatic inflammation is more than just skin deep","volume":"21","author":"Kommoss","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.semerg.2026.102845_bib0285","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semerg.2026.102845_bib0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s13205-020-2089-6","article-title":"Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies","volume":"10","author":"Choudhary","year":"2020","journal-title":"3 Biotech"},{"key":"10.1016\/j.semerg.2026.102845_bib0295","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study","volume":"33","author":"Fern\u00e1ndez-Armenteros","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semerg.2026.102845_bib0305","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/jdv.13634","article-title":"Psoriasis registries worldwide: systematic overview on registry publications","volume":"30","author":"Eissing","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semerg.2026.102845_bib0310","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102845_bib0315","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.semerg.2026.102845_bib0320","first-page":"S13","article-title":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semerg.2026.102845_bib0325","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semerg.2026.102845_bib0330","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.semerg.2026.102845_bib0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S1138741600006004","article-title":"Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS)","volume":"9","author":"Remor","year":"2006","journal-title":"Span J Psychol"},{"key":"10.1016\/j.semerg.2026.102845_bib0340","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0345","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00403-024-02999-x","article-title":"A cross-sectional study of psoriasis hospitalizations in patients with cardiovascular comorbidities in patients under 60","volume":"316","author":"Eckembrecher","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semerg.2026.102845_bib0350","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jdv.14835","article-title":"Psoriasis and cardiovascular disease risk factors: the HUNT Study, Norway","volume":"32","author":"Snekvik","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semerg.2026.102845_bib0355","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semerg.2026.102845_bib0360","doi-asserted-by":"crossref","first-page":"e15060","DOI":"10.1111\/exd.15060","article-title":"Clinical profile, treatment and quality of life of patients with psoriatic arthritis in Malaysia: a population-based cross-sectional study","volume":"33","author":"Goh","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0365","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5021\/ad.2017.29.4.462","article-title":"The clinical profile of patients with psoriasis in Korea: a nationwide cross-sectional study (EPI-PSODE)","volume":"29","author":"Song","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0370","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalence of psoriasis in Spain in the age of biologics","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semerg.2026.102845_bib0375","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ad.2018.10.015","article-title":"Epidemiology of psoriasis. A population-based study","volume":"110","author":"Fern\u00e1ndez-Armenteros","year":"2019","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.semerg.2026.102845_bib0380","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijms19010058","article-title":"Cardiometabolic comorbidities in psoriasis and psoriatic arthritis","volume":"19","author":"Puig","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semerg.2026.102845_bib0385","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ad.2020.11.017","article-title":"Burden of psoriasis in catalonia: epidemiology, associated comorbidities, health care utilization, and sick leave","volume":"112","author":"Puig","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.semerg.2026.102845_bib0390","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ad.2013.02.018","article-title":"Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study","volume":"104","author":"Daud\u00e9n","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semerg.2026.102845_bib0395","doi-asserted-by":"crossref","first-page":"T539","DOI":"10.1016\/j.ad.2024.04.013","article-title":"Epidemiological, clinical, and allergic profile of psoriatic patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)","volume":"115","author":"Verdaguer-Faja","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semerg.2026.102845_bib0400","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semerg.2020.06.027","article-title":"Factors associated with cardiovascular risk and cardiovascular and renal disease in the IBERICAN study: final results","volume":"46","author":"Cinza-Sanjurjo","year":"2020","journal-title":"Semergen"},{"key":"10.1016\/j.semerg.2026.102845_bib0405","first-page":"821","article-title":"Integrated assessment of inflammatory and lipid-metabolic biomarkers in psoriasis: implications for metabolic syndrome","volume":"16","author":"Nistor","year":"2026","journal-title":"Life (Basel)"},{"key":"10.1016\/j.semerg.2026.102845_bib0410","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2026.2673285","article-title":"Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome","volume":"37","author":"Gisondi","year":"2026","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semerg.2026.102845_bib0415","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.semerg.2026.102845_bib0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: an analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semerg.2026.102845_bib0425","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.semerg.2026.102845_bib0430","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom","volume":"151","author":"Takeshita","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.semerg.2026.102845_bib0435","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.2147\/DMSO.S273147","article-title":"Diabetes and psoriasis: different sides of the same prism","volume":"13","author":"Abramczyk","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.semerg.2026.102845_bib0440","article-title":"Psoriasis and diabetes, a dangerous association: evaluation of insulin resistance, lipid abnormalities, and cardiovascular risk biomarkers","volume":"8","author":"Brazzelli","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semerg.2026.102845_bib0445","doi-asserted-by":"crossref","first-page":"829709","DOI":"10.3389\/fcvm.2022.829709","article-title":"Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.semerg.2026.102845_bib0450","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.113","article-title":"Psoriasis and risk of heart failure: a nationwide cohort study","volume":"16","author":"Khalid","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semerg.2026.102845_bib0455","article-title":"Association of psoriasis with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis","volume":"10","author":"Jing","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semerg.2026.102845_bib0460","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/biomedicines12010249","article-title":"Association between psoriasis and renal functions: an integration study of observational study and Mendelian randomization","volume":"12","author":"Tan","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.semerg.2026.102845_bib0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.11622\/smedj.2021026","article-title":"Management of psoriasis in primary care","volume":"62","author":"Lim","year":"2021","journal-title":"Singap Med J"},{"key":"10.1016\/j.semerg.2026.102845_bib0470","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMe2314345","article-title":"Psoriasis \u2013 more progress but more questions","volume":"390","author":"Gelfand","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:14:43Z","timestamp":1795018483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1138359326001620"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102845","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk factors and their evolution in a primary care psoriasis cohort: The REPICA study","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102845"}}